No apparent benefit of liquid formula diet in NIDDM

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 3, 1997, Pages 134-139

  Printz, H ^a   Recke, B ^a   Fehmann, H C ^a   Goke B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Diabetes mellitus; Enteral diets; Entero insular axis; Incretin hormones

Indexed keywords

C PEPTIDE; CARBOHYDRATE; FRUCTOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLIBENCLAMIDE; HORMONE; INSULIN; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY FIBER; ENTERIC FEEDING; FEMALE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030878148     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211741     Document Type: Article

References (25)

1. American Diabetes Association: Clinical practice recommendations 1996. Diabetes Care 19: (Suppl 1) S 16, 1996.
2. Coniff RF, Shapiro JA, Seaton TB: Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus. Arch Intern Med 154: 2442-2448, 1994.
3. Crapo PA: Dietary management. In: Kahn CR, Weir GC (eds.). Joslin's diabetes mellitus, chapter 24. pp. 415-430, Len & Febinger, Philadelphia, 1994.
4. Deutsche Diabetes-Gesellschaft: Grundlagen der Ernährung und Diätempfehlungen für Diabetiker. Akt Ernähr 15: 27-38, 1990.
5. Ebert R, Creutzfeldt W: Decreased GIP secretion through impairment of absorption. Front Horm Res 7: 192-201, 1980.
6. Eissele R, Göke R, Willemer S, Harthus HP, Vermeer H, Arnold R, Göke B: Glucagon-like peptide 1 (7-36) amide-cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22: 283-291, 1992.
7. Fehmann HC, Göke R, Göke B: Cell and molecular biology of the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulin releasing polypeptide (GIP). Endocrine Rev 16: 390-410, 1995.
8. Fukase N, Manaka H, Sugiyama K, Takahashi H, Igarashi M, Daimon M, Yamatani K, Tominaga M, Sasaki H: Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus. Acta Diabetologica 32:165-169, 1995.
9. Göke B, Fuder H, Wieckhorst G, Theiß U, Stridde E, Littke T, Kleist P, Arnold R, Lücker PW: Voglibose (A-128) is an efficient α-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion 56: 493-501, 1995.
10. Göke B, Hermann C, Göke R, Fehmann HC, Berghöfer P, Richter G, Arnold R: Intestinal effects of α-glucosidase inhibitors: Absorption of nutrients and enterohormonal changes. Eur J Clin Invest 24 (Suppl 3): 25-30, 1994.
11. Haslbeck M, Stiller R, Niederreiter B: Günstige metabolische Wirkungen einer kohlenhydratmodifizierten, bilanzierten Diät bei Typ-II-Diabetes. Akt Ernähr Med 20: 215-220, 1995.
12. Hanefeld M, Fischer S, Schulze J, Spengler M, Wargenau M, Schollberg K, Fücker K: Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 14: 732-737, 1991.
13. Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R, Göke B: Glucagon-like peptide 1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56: 117-126, 1995.
14. Järvi AE, Karlström BE, Granfeldt YE, Björck IME, Vessby BOH, Asp NGL: The influence of food structure on postprandial metabolism in patients with non-insulin dependent diabetes mellitus. Am J Clin Nutr 61: 837-842, 1995.
15. Morgan LM, Goulder TJ, Tsiolakis D, Marks V, Alberti KGMM: The effect of unabsorbable carbohydrate on gut hormones. Diabetologia 17: 85-89, 1979.
16. Otto C, Sönnichsen AC, Ritter MM, Richter WO, Schwandt P: Influence of fiber, xylitol and fructose in enteral formulas on glucose and lipid metabolism in normal subjects. Clin Invest 71: 290-293, 1993.
17. Peters AL, Davidson MB: Challenge of blood glucose management in diabetic patients receiving enteral or parenteral nutrition. JPEN 17: 1-2, 1993.
18. Philipps ML: Enteral nutrition support in diabetes mellitus. Nutr Clin Pract 2: 152-154, 1987.
19. Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W: Glucagon-like peptide 1 (7-36) amide secretion in response to luminal sucrose from the upper and lower gut. Scand J Gastroenterol 30: 892-896, 1995.
20. Richter G, Schilling T, Göke B: Challenge of the entero-insular axis in healthy volunteers by liquid diets modified for the enteral nutrition of patients with diabetes mellitus. Akt Ernähr Med 20:122-126, 1995.
21. Schiller HJ, Galvin M, Meguid MM: Acute nutrition management in insulin-dependent diabetes: presentation of an index case. Nutrition 9: 360-365, 1993.
22. Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B: Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97: 92-103, 1996.
23. Southgate DAT: Digestion and metabolism of sugars. Am J Clin Nutr 62 (Suppl): 203S-211S, 1995.
24. Stürmer W, Kramer E, Kasper H, Schrezenmeir J: Favourable glycaemic effects of a new balanced liquid diet for enteral nutrition - results of a short-term study in 30 type II diabetic patients. Clin Nutrition 13: 221-227, 1994.
25. Wolever TMS, Miller BJ: Sugars and blood glucose control. Am J Clin Nutr 62: 212S-227S, 1995.